Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

NCT02080195 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study was unable to accrue subjects

Conditions

Lupus Erythematosus
Graft-versus-host Disease

Interventions

DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
DRUG: Rabbit antithymocyte globulin
RADIATION: Total body irradiation
BIOLOGICAL: Allogeneic bone marrow transplant

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]